Variant report

Variant	nsv1009532
Chromosome Location	chr2:40165606-40291224
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:440)
CpG islands
(count:244)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:440 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:40217162-40217725	K562	blood:	n/a	n/a
2	ATF1	chr2:40223765-40224372	K562	blood:	n/a	n/a
3	ATF1	chr2:40222613-40222712	K562	blood:	n/a	n/a
4	BACH1	chr2:40208471-40208655	H1-hESC	embryonic stem cell:	n/a	n/a
5	CBX3	chr2:40223784-40224393	HCT-116	colon:	n/a	n/a
6	CCNT2	chr2:40224014-40224213	K562	blood:	n/a	n/a
7	CCNT2	chr2:40279953-40280153	K562	blood:	n/a	n/a
8	CEBPB	chr2:40288200-40288530	HepG2	liver:	n/a	chr2:40288341-40288352
9	CEBPB	chr2:40194850-40195177	HepG2	liver:	n/a	chr2:40195008-40195019
10	CEBPB	chr2:40223752-40224243	IMR90	lung:	n/a	n/a
11	CEBPB	chr2:40194970-40195037	K562	blood:	n/a	chr2:40195008-40195019
12	CEBPB	chr2:40223865-40224375	HCT-116	colon:	n/a	n/a
13	CEBPB	chr2:40259963-40260548	IMR90	lung:	n/a	n/a
14	CEBPB	chr2:40218557-40218771	H1-hESC	embryonic stem cell:	n/a	chr2:40218674-40218685
15	CEBPB	chr2:40269113-40269506	IMR90	lung:	n/a	n/a
16	CEBPB	chr2:40218529-40218785	HepG2	liver:	n/a	chr2:40218674-40218685
17	CEBPB	chr2:40243495-40243987	IMR90	lung:	n/a	chr2:40243790-40243803 chr2:40243792-40243803
18	CEBPB	chr2:40288194-40288467	IMR90	lung:	n/a	chr2:40288341-40288352
19	CEBPB	chr2:40286576-40286696	HepG2	liver:	n/a	n/a
20	CEBPB	chr2:40223859-40224267	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr2:40258067-40258360	K562	blood:	n/a	chr2:40258206-40258217
22	CEBPB	chr2:40218494-40218859	IMR90	lung:	n/a	chr2:40218674-40218685
23	CEBPB	chr2:40187092-40187228	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr2:40258083-40258389	HepG2	liver:	n/a	chr2:40258206-40258217
25	CEBPB	chr2:40194890-40195200	A549	lung:	n/a	chr2:40195008-40195019
26	CEBPB	chr2:40223962-40224177	A549	lung:	n/a	n/a
27	CEBPB	chr2:40258041-40258398	IMR90	lung:	n/a	chr2:40258206-40258217
28	CEBPB	chr2:40218547-40218785	A549	lung:	n/a	chr2:40218674-40218685
29	CEBPB	chr2:40187059-40187300	IMR90	lung:	n/a	n/a
30	CEBPB	chr2:40221391-40221660	IMR90	lung:	n/a	n/a
31	CEBPB	chr2:40266300-40266894	IMR90	lung:	n/a	n/a
32	CEBPB	chr2:40223679-40224438	HCT-116	colon:	n/a	n/a
33	CEBPB	chr2:40194909-40195167	H1-hESC	embryonic stem cell:	n/a	chr2:40195008-40195019
34	CEBPB	chr2:40243703-40243880	A549	lung:	n/a	chr2:40243790-40243803 chr2:40243792-40243803
35	CEBPB	chr2:40258064-40258380	A549	lung:	n/a	chr2:40258206-40258217
36	CHD2	chr2:40223919-40224266	Hela-S3	cervix:	n/a	n/a
37	CTCF	chr2:40216540-40216690	NHEK	skin:	n/a	n/a
38	CTCF	chr2:40269280-40269430	AG10803	skin:	n/a	n/a
39	CTCF	chr2:40235320-40235470	GM12871	blood:	n/a	n/a
40	CTCF	chr2:40190380-40190530	GM12869	blood:	n/a	n/a
41	CTCF	chr2:40190480-40190630	GM12868	blood:	n/a	n/a
42	CTCF	chr2:40235362-40235412	MCF-7	breast:	n/a	n/a
43	CTCF	chr2:40190220-40190370	Hela-S3	cervix:	n/a	n/a
44	CTCF	chr2:40269220-40269370	HBMEC	blood vessel:	n/a	n/a
45	CTCF	chr2:40190280-40190430	HEK293	kidney:	n/a	n/a
46	CTCF	chr2:40187346-40187369	Kidney_OC	kidney:	n/a	n/a
47	CTCF	chr2:40216520-40216670	HMEC	breast:	n/a	n/a
48	CTCF	chr2:40235360-40235510	MCF-7	breast:	n/a	n/a
49	CTCF	chr2:40261440-40261590	HMF	breast:	n/a	n/a
50	CTCF	chr2:40190320-40190470	WI-38	lung:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:40260498-40260548	HRCEpiC	kidney:	n/a
2	chr2:40260498-40260548	MCF-7	breast:	n/a
3	chr2:40266366-40266416	HCT-116	colon:	n/a
4	chr2:40165558-40165608	AG09309	skin:	n/a
5	chr2:40266366-40266416	NB4	blood:	n/a
6	chr2:40203342-40203392	Hepatocyte	liver:	n/a
7	chr2:40165558-40165608	HAEpiC	amniotic membrane:	n/a
8	chr2:40165558-40165608	AG04450	lung:	fetal
9	chr2:40260498-40260548	Hela-S3	cervix:	n/a
10	chr2:40266366-40266416	HMEC	breast:	n/a
11	chr2:40203342-40203392	PFSK-1	brain:	n/a
12	chr2:40165558-40165608	NH-A	brain:	n/a
13	chr2:40203342-40203392	Jurkat	blood:	n/a
14	chr2:40260498-40260548	HRE	kidney:	n/a
15	chr2:40260498-40260548	HPAEpiC	pulmonary alveolar:	n/a
16	chr2:40260498-40260548	HNPCEpiC	eye:	n/a
17	chr2:40266366-40266416	HAEpiC	amniotic membrane:	n/a
18	chr2:40266366-40266416	SAEC	small airway:	n/a
19	chr2:40165558-40165608	ovcar-3	ovarian:	n/a
20	chr2:40165558-40165608	Caco-2	colon:	n/a
21	chr2:40165558-40165608	GM19239	blood:	n/a
22	chr2:40165558-40165608	MCF-7	breast:	n/a
23	chr2:40165558-40165608	BE2_C	brain:	n/a
24	chr2:40203342-40203392	GM12878	blood:	n/a
25	chr2:40266366-40266416	HRCEpiC	kidney:	n/a
26	chr2:40260498-40260548	H1-hESC	embryonic stem cell:	embryo
27	chr2:40266366-40266416	AG04450	lung:	fetal
28	chr2:40260498-40260548	AG04450	lung:	fetal
29	chr2:40260498-40260548	PrEC	prostate:	n/a
30	chr2:40165558-40165608	HL-60	blood:	n/a
31	chr2:40203342-40203392	K562	blood:	n/a
32	chr2:40165558-40165608	A549	lung:	n/a
33	chr2:40260498-40260548	CMK	blood:	n/a
34	chr2:40165558-40165608	MCF10A-Er-Src	breast:	n/a
35	chr2:40203342-40203392	IMR90	lung:	fetal
36	chr2:40165558-40165608	HCM	heart:	n/a
37	chr2:40203342-40203392	HCPEpiC	choroid plexus:	n/a
38	chr2:40203342-40203392	AG04450	lung:	fetal
39	chr2:40260498-40260548	A549	lung:	n/a
40	chr2:40260498-40260548	SKMC	muscle:	n/a
41	chr2:40165558-40165608	Jurkat	blood:	n/a
42	chr2:40165558-40165608	PFSK-1	brain:	n/a
43	chr2:40203342-40203392	NHDF-neo	bronchial:	n/a
44	chr2:40203342-40203392	ovcar-3	ovarian:	n/a
45	chr2:40203342-40203392	HEEpiC	esophagus:	n/a
46	chr2:40266366-40266416	Caco-2	colon:	n/a
47	chr2:40266366-40266416	T-47D	breast:	n/a
48	chr2:40165558-40165608	HEEpiC	esophagus:	n/a
49	chr2:40165558-40165608	SK-N-SH_RA	brain:	n/a
50	chr2:40203342-40203392	HCF	heart:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:
2	chr2:40248216..40251072-chr2:40272085..40274359,2	K562	blood:
3	chr2:40164512..40166990-chr2:40173493..40175018,2	MCF-7	breast:
4	chr2:40164512..40166990-chr2:40173493..40175018,2	MCF-7	breast:
5	chr2:40248216..40251072-chr2:40272085..40274359,2	K562	blood:
6	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM178-2	chr2:40270558-40270682	ENSG00000227028.1
2	lnc-TMEM178-2	chr2:40185553-40185606	ucscGeneNc_uc002rrw_2
3	lnc-TMEM178-2	chr2:40269490-40269613	ENSG00000227028.1

No data

Variant related genes	Relation type
SLC8A1-AS1	TF binding region
SLC8A1-AS1	CpG island

Extended variants
information (count: 7146 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:7146 , 50 per page) page: 1 2 3 4 5 6 7 ... 143

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs559701374	chr2:40165613-40165614	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs191017263	chr2:40165614-40165615	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs551402207	chr2:40165621-40165622	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs141063265	chr2:40165641-40165642	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs58096789	chr2:40165715-40165716	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs377465262	chr2:40165718-40165719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs183531140	chr2:40165733-40165734	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs115870783	chr2:40165802-40165803	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs186627239	chr2:40165813-40165814	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs554008444	chr2:40165848-40165849	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs559868000	chr2:40165855-40165856	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs539401680	chr2:40165893-40165894	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs558139315	chr2:40165902-40165903	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs72934832	chr2:40165904-40165905	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs543941099	chr2:40165917-40165918	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs117431957	chr2:40165956-40165957	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs144890908	chr2:40165976-40165977	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs191439029	chr2:40166003-40166004	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs559642243	chr2:40166020-40166021	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs533275092	chr2:40166037-40166038	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs733958	chr2:40166051-40166052	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs182853848	chr2:40166107-40166108	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs17024636	chr2:40166131-40166132	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs529314199	chr2:40166132-40166133	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs188319455	chr2:40166142-40166143	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs567264423	chr2:40166183-40166184	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs529418933	chr2:40166189-40166190	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs192770937	chr2:40166205-40166206	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs185200210	chr2:40166270-40166271	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs539781053	chr2:40166308-40166309	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs557862642	chr2:40166339-40166340	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs570058240	chr2:40166343-40166344	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs550674004	chr2:40166349-40166350	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs80328779	chr2:40166357-40166358	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs555804474	chr2:40166383-40166384	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs190181086	chr2:40166385-40166386	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs192457056	chr2:40166432-40166433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs553244944	chr2:40166435-40166436	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs577996681	chr2:40166436-40166437	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs141554627	chr2:40166450-40166451	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs563123019	chr2:40166467-40166468	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs184743923	chr2:40166488-40166489	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs35621304	chr2:40166570-40166571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs737589	chr2:40166596-40166597	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs114157191	chr2:40166607-40166608	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs187975406	chr2:40166698-40166699	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs180934596	chr2:40166713-40166714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs565977371	chr2:40166741-40166742	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs533422519	chr2:40166745-40166746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs550023633	chr2:40166866-40166867	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Non-small cell lung cancer	18927303	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Williams Syndrome	20824207	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:454 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:40147000-40167400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr2:40164600-40166400	Flanking Active TSS	Dnd41	blood
3	chr2:40164800-40166000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr2:40164800-40166200	Enhancers	Fetal Thymus	thymus
5	chr2:40164800-40166400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
6	chr2:40164800-40166400	Enhancers	HSMM	muscle
7	chr2:40164800-40166400	Enhancers	Osteobl	bone
8	chr2:40165000-40166400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr2:40165000-40166600	Enhancers	Muscle Satellite Cultured Cells	--
10	chr2:40165000-40166600	Enhancers	NH-A	brain
11	chr2:40165000-40166800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr2:40165000-40175800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr2:40165200-40166000	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr2:40165200-40166400	Enhancers	HUES64 Cell Line	embryonic stem cell
15	chr2:40165200-40166400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:40165400-40165800	Enhancers	Thymus	Thymus
17	chr2:40165400-40166400	Enhancers	HMEC	breast
18	chr2:40165600-40169400	Weak transcription	HSMMtube	muscle
19	chr2:40165600-40175200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr2:40166400-40168200	Enhancers	Dnd41	blood
21	chr2:40166400-40169400	Weak transcription	HSMM	muscle
22	chr2:40166400-40169800	Weak transcription	Osteobl	bone
23	chr2:40166600-40169600	Weak transcription	NH-A	brain
24	chr2:40166600-40170000	Weak transcription	Muscle Satellite Cultured Cells	--
25	chr2:40166800-40167200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr2:40166800-40168400	Weak transcription	Fetal Thymus	thymus
27	chr2:40167200-40167400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr2:40167400-40167600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr2:40167400-40170200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr2:40167600-40167800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr2:40169400-40170600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
32	chr2:40169400-40170600	Enhancers	Dnd41	blood
33	chr2:40169400-40170600	Enhancers	HSMM	muscle
34	chr2:40169400-40170600	Enhancers	HSMMtube	muscle
35	chr2:40169400-40170800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr2:40169600-40170000	Enhancers	NH-A	brain
37	chr2:40169800-40170600	Enhancers	Osteobl	bone
38	chr2:40170000-40170600	Enhancers	Muscle Satellite Cultured Cells	--
39	chr2:40170000-40174600	Weak transcription	NH-A	brain
40	chr2:40170200-40170600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr2:40170200-40170600	Enhancers	NHDF-Ad	bronchial
42	chr2:40170600-40171600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
43	chr2:40170600-40171600	Weak transcription	HSMMtube	muscle
44	chr2:40170600-40173600	Weak transcription	Dnd41	blood
45	chr2:40170600-40173800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr2:40170600-40174200	Weak transcription	NHDF-Ad	bronchial
47	chr2:40170600-40174400	Weak transcription	Muscle Satellite Cultured Cells	--
48	chr2:40170600-40174400	Weak transcription	HSMM	muscle
49	chr2:40170600-40174400	Weak transcription	Osteobl	bone
50	chr2:40170800-40174600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links